{
  "Complete Blood Count (CBC)": "Thrombocytopenia (low platelet count), anemia (low red blood cell count), and leukopenia (low white blood cell count) due to bone marrow suppression.",
  "Liver Function Tests (ALT, AST, Bilirubin)": "Elevated levels indicating hepatotoxicity or liver dysfunction.",
  "Renal Function Tests (Creatinine, BUN)": "Potentially elevated levels due to nephrotoxicity or concurrent use with other nephrotoxic drugs.",
  "Lipid Profile (Cholesterol, Triglycerides)": "Elevated cholesterol and triglycerides, increasing cardiovascular risk.",
  "Serum Electrolytes (Potassium, Magnesium, Sodium)": "Potential imbalances, such as hyperkalemia (high potassium) or hypomagnesemia (low magnesium).",
  "C-Reactive Protein (CRP)": "Reduced levels due to suppression of immune responses, though variable depending on the underlying condition.",
  "Erythrocyte Sedimentation Rate (ESR)": "Reduced levels due to suppression of inflammation.",
  "Trough Sirolimus Levels": "Abnormal therapeutic drug levels (too high or too low), affecting efficacy or toxicity.",
  "Urinalysis": "Proteinuria or hematuria in cases of renal dysfunction.",
  "Serum Glucose": "Hyperglycemia due to metabolic side effects, particularly in patients at risk for diabetes.",
  "Serum LDH": "Elevated levels in cases of tissue damage or hemolysis.",
  "Bone Marrow Biopsy": "May show hypocellularity in cases of significant cytopenias.",
  "Serum Immunoglobulins (IgG, IgA, IgM)": "Reduced levels due to immunosuppressive effects on B-cell function.",
  "Vitamin D and Calcium": "Low levels associated with impaired bone metabolism and increased fracture risk.",
  "Parathyroid Hormone (PTH)": "Elevated levels in cases of secondary hyperparathyroidism due to renal involvement.",
  "Pulmonary Function Tests (PFTs)": "Abnormal results if pulmonary toxicity or pneumonitis occurs."
}
